vs
Side-by-side financial comparison of CSP INC (CSPI) and JOINT Corp (JYNT). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $12.0M, roughly 1.3× CSP INC). JOINT Corp runs the higher net margin — 6.5% vs 0.8%, a 5.8% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs -23.2%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-3.0M). Over the past eight quarters, CSP INC's revenue compounded faster (-6.3% CAGR vs -28.6%).
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
CSPI vs JYNT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $15.2M |
| Net Profit | $91.0K | $991.1K |
| Gross Margin | 39.3% | 81.4% |
| Operating Margin | -0.9% | 4.9% |
| Net Margin | 0.8% | 6.5% |
| Revenue YoY | -23.2% | 3.1% |
| Net Profit YoY | -80.7% | 5510.5% |
| EPS (diluted) | $0.01 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.0M | $15.2M | ||
| Q3 25 | $14.5M | $13.4M | ||
| Q2 25 | $15.4M | $13.3M | ||
| Q1 25 | $13.1M | $13.1M | ||
| Q4 24 | $15.7M | $14.7M | ||
| Q3 24 | $13.0M | $30.2M | ||
| Q2 24 | $13.1M | $30.3M | ||
| Q1 24 | $13.7M | $29.7M |
| Q4 25 | $91.0K | $991.1K | ||
| Q3 25 | $-191.0K | $855.0K | ||
| Q2 25 | $-264.0K | $93.4K | ||
| Q1 25 | $-108.0K | $967.8K | ||
| Q4 24 | $472.0K | $17.7K | ||
| Q3 24 | $-1.7M | $-3.2M | ||
| Q2 24 | $-185.0K | $-3.6M | ||
| Q1 24 | $1.6M | $947.0K |
| Q4 25 | 39.3% | 81.4% | ||
| Q3 25 | 36.6% | 80.1% | ||
| Q2 25 | 28.8% | 79.1% | ||
| Q1 25 | 32.0% | 77.3% | ||
| Q4 24 | 29.1% | 78.4% | ||
| Q3 24 | 28.4% | 90.7% | ||
| Q2 24 | 35.0% | 90.7% | ||
| Q1 24 | 47.3% | 90.9% |
| Q4 25 | -0.9% | 4.9% | ||
| Q3 25 | -3.7% | 1.2% | ||
| Q2 25 | -7.9% | -8.6% | ||
| Q1 25 | -7.6% | -5.2% | ||
| Q4 24 | -2.3% | 5.5% | ||
| Q3 24 | -15.7% | -1.6% | ||
| Q2 24 | -5.5% | -5.9% | ||
| Q1 24 | 9.0% | -1.4% |
| Q4 25 | 0.8% | 6.5% | ||
| Q3 25 | -1.3% | 6.4% | ||
| Q2 25 | -1.7% | 0.7% | ||
| Q1 25 | -0.8% | 7.4% | ||
| Q4 24 | 3.0% | 0.1% | ||
| Q3 24 | -12.7% | -10.5% | ||
| Q2 24 | -1.4% | -11.9% | ||
| Q1 24 | 11.6% | 3.2% |
| Q4 25 | $0.01 | $0.06 | ||
| Q3 25 | $-0.02 | $0.06 | ||
| Q2 25 | $-0.03 | $0.01 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $0.05 | $0.01 | ||
| Q3 24 | $-0.17 | $-0.21 | ||
| Q2 24 | $-0.02 | $-0.24 | ||
| Q1 24 | $0.16 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $23.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8M | $15.1M |
| Total Assets | $69.2M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $23.6M | ||
| Q3 25 | $27.4M | $29.7M | ||
| Q2 25 | $26.3M | $29.8M | ||
| Q1 25 | $29.5M | $21.9M | ||
| Q4 24 | $30.7M | $25.1M | ||
| Q3 24 | $30.6M | $20.7M | ||
| Q2 24 | $28.9M | $17.5M | ||
| Q1 24 | $27.1M | $18.7M |
| Q4 25 | $44.8M | $15.1M | ||
| Q3 25 | $44.6M | $22.7M | ||
| Q2 25 | $47.5M | $23.2M | ||
| Q1 25 | $47.5M | $22.8M | ||
| Q4 24 | $47.5M | $20.7M | ||
| Q3 24 | $47.3M | $20.5M | ||
| Q2 24 | $48.1M | $23.2M | ||
| Q1 24 | $48.2M | $26.2M |
| Q4 25 | $69.2M | $61.0M | ||
| Q3 25 | $71.2M | $69.4M | ||
| Q2 25 | $66.8M | $73.2M | ||
| Q1 25 | $67.1M | $80.1M | ||
| Q4 24 | $67.5M | $83.2M | ||
| Q3 24 | $69.4M | $79.6M | ||
| Q2 24 | $66.8M | $82.4M | ||
| Q1 24 | $64.2M | $85.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $1.8M |
| Free Cash FlowOCF − Capex | $-3.0M | $334.7K |
| FCF MarginFCF / Revenue | -25.1% | 2.2% |
| Capex IntensityCapex / Revenue | 0.9% | 9.9% |
| Cash ConversionOCF / Net Profit | -32.04× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.8M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $1.8M | ||
| Q3 25 | $1.9M | $1.8M | ||
| Q2 25 | $-3.3M | $868.6K | ||
| Q1 25 | $1.9M | $-3.7M | ||
| Q4 24 | $1.7M | $9.4M | ||
| Q3 24 | $-1.5M | $3.4M | ||
| Q2 24 | $2.4M | $-973.5K | ||
| Q1 24 | $1.7M | $2.8M |
| Q4 25 | $-3.0M | $334.7K | ||
| Q3 25 | $1.7M | $1.5M | ||
| Q2 25 | $-3.3M | $363.6K | ||
| Q1 25 | $1.9M | $-4.0M | ||
| Q4 24 | $1.7M | $8.2M | ||
| Q3 24 | $-1.5M | $3.2M | ||
| Q2 24 | $2.4M | $-1.2M | ||
| Q1 24 | $1.6M | $2.4M |
| Q4 25 | -25.1% | 2.2% | ||
| Q3 25 | 11.5% | 10.9% | ||
| Q2 25 | -21.7% | 2.7% | ||
| Q1 25 | 14.5% | -30.8% | ||
| Q4 24 | 10.8% | 55.9% | ||
| Q3 24 | -11.7% | 10.6% | ||
| Q2 24 | 17.9% | -4.1% | ||
| Q1 24 | 11.9% | 8.1% |
| Q4 25 | 0.9% | 9.9% | ||
| Q3 25 | 1.6% | 2.4% | ||
| Q2 25 | 0.4% | 3.8% | ||
| Q1 25 | 0.1% | 2.5% | ||
| Q4 24 | 0.3% | 8.1% | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 0.3% | 0.9% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | -32.04× | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | 3.69× | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.04× | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
